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ABSTRACT The Echinococcus granulosus actin ﬁlament-fragmenting protein (EgAFFP) is a three domain member of the
gelsolin family of proteins, which is antigenic to human hosts. These proteins, formed by three or six conserved domains, are
involved in the dynamic rearrangements of the cytoskeleton, being responsible for severing and capping actin ﬁlaments and
promoting nucleation of actin monomers. Various structures of six domain gelsolin-related proteins have been investigated, but
little information on the structure of three domain members is available. In this work, the solution structure of the three domain
EgAFFP has been investigated through small-angle x-ray scattering (SAXS) studies. EgAFFP exhibits an elongated molecular
shape. The radius of gyration and the maximum dimension obtained by SAXS were, respectively, 2.52 6 0.01 nm and 8.00 6
1.00 nm, both in the absence and presence of Ca21. Two different molecular homology models were built for EgAFFP, but only
one was validated through SAXS studies. The predicted structure for EgAFFP consists of three repeats of a central b-sheet
sandwiched between one short and one long a-helix. Possible implications of the structure of EgAFFP upon actin binding are
discussed.
INTRODUCTION
The larval stage of the cestode tapeworm Echinococcus
granulosus is the causative agent of cystic hydatid disease or
hydatidosis, recognized as one of the world’s major zoono-
ses (1). This parasite requires two mammalian hosts for
completion of its life cycle. Adult tapeworms develop in the
small intestine of deﬁnitive hosts (domestic dogs and wild
canids), whereas the metacestode or hydatid cyst usually
develops in the liver or lungs of intermediate hosts (mainly in
ungulates, and accidentally in humans). The pathological
effect of the disease is caused by the pressure exerted by the
hydatid cyst on the intermediate host’s viscera. Within the
cyst, protoscoleces are produced by asexual reproduction and
develop into the adult worm when ingested by the deﬁnitive
host.
The E. granulosus complex life cycle involves important
changes in cell morphology and physiology (2). The molec-
ular and cellular mechanisms involved in E. granulosus de-
velopment are still largely unknown but are likely to require
extensive cytoskeleton reorganization (3,4).
The actin cytoskeleton is a vital component of several key
cellular and developmental processes in eukaryotes, such as
motility, cytokinesis, cytoplasmic organization, and endo-
cytosis (5). In cells, the assembly and disassembly of actin
ﬁlaments, in addition to their organization into functional
three-dimensional (3D) networks, are regulated by a variety
of actin-binding proteins (6–10). Among these proteins,
those from the gelsolin superfamily control actin organiza-
tion by severing ﬁlaments, capping ﬁlament ends, and nu-
cleating actin assembly (11).
The best-studied members of this protein family are
severin (12–14) and fragmin (15,16) from Dictyostelium
discoideum and Physarum polycephalum, respectively, and
gelsolin (17,18) and villin (19,20) from higher organisms. A
common feature of this family is the segmental organization
into three (severin, fragmin) or six (gelsolin, villin) homol-
ogous domains that might have evolved from an ancestral
one domain protein through a stepwise process, involving a
gene triplication followed by an additional duplication event
(21,17). The activities of these proteins are often modulated
by signaling molecules, such as Ca21 or phosphorylated
phosphoinositides (22). Based on gelsolin (23,24), the most
extensively studied member of the family, it is generally
accepted that the second domain binds F-actin, whereas the
ﬁrst domain (and the fourth one, for six domain proteins)
binds G-actin.
So far, only a few proteins of the gelsolin superfamily
have solved 3D structures. A search in the database of pro-
tein structures indicates that of all known members of this
family to date, gelsolin is the only protein that has its full-
length (six domains) structure solved (25). Structures of
other proteins, like villin (26) and severin (27,28), have been
determined only for the ﬁrst or second domains, usually
bound to ligands (Ca21 and/or actin). Domain comparisons
between the known structures show that they all share a
common fold built around a central ﬁve-stranded mixed
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b-sheet, which is ﬂanked by a long a-helix running parallel to
the sheet and a short perpendicular running a-helix (25–29).
Our laboratory has previously cloned and functionally
characterized a 42 kDa actin ﬁlament-fragmenting pro-
tein from E. granulosus (EgAFFP) (30). The recombinant
EgAFFP protein is recognized by sera of ;69% of human
hydatid disease patients (31) and, in vitro, was able to induce
actin polymerization and sever actin ﬁlaments, conﬁrming
that it belongs to the gelsolin superfamily (30). According to
sequence analysis, EgAFFP presents three repeated domains
and is similar (36% identity) to the gelsolin NH2-terminal
half (G1–G3). The lack of structural data for full-length
three domain members of the gelsolin superfamily, such
as EgAFFP, represents an obstacle to the understanding of
structure-function relationships of these smaller proteins,
which are functionally equivalent to their six domain coun-
terparts. Structural characterization of EgAFFP might help to
understand how three domain members function and how
they are regulated by calcium.
There is a relatively high degree of sequence identity
between gelsolin and orthologous proteins, such as villin and
severin, particularly in regions that are buried or forming
secondary structure (25). Therefore, it has been suggested that
the domain folds in gelsolin may be used to predict the ge-
ometries for the as of yet unsolved structures of the corre-
sponding domains in othermembers of the gelsolin superfamily.
Homology or comparative protein structure modeling allows
the construction of a 3D model for a given protein sequence
based on its similarity to one or more known structures. It is
the most reliable method to predict the 3D structure of a
protein, with an accuracy that can be comparable to that of a
low resolution, experimentally determined structure (32). The
accuracy of comparative modeling is correlated with sequence
identity between the template structure and the modeled
sequence (33). High accuracy models can be obtained when
template structureswith.50% sequence identity are available,
medium accuracywith 30%6 50% sequence identity, and low
accuracy with,30% sequence identity.
Small-angle x-ray scattering (SAXS) is a well-established
technique for obtaining structural information on macromol-
ecules in solution under close to physiological conditions
(34) and is particularly useful when high resolution structural
information, such as that from NMR or x-ray crystallogra-
phy, is not yet available (35) as is the case for EgAFFP.
Previous work has shown that SAXS data can be conve-
niently used to conﬁrm computer-modeled protein structures
(36,37).
In this study, we constructed a homology model for
EgAFFP both in the presence and in the absence of Ca21,
based on its similarity with horse plasma gelsolin (Protein
Data Bank (PDB) id: 1RGI (38) and 1D0N (25), respec-
tively). We also obtained an ab initio low resolution model of
EgAFFP through SAXS studies, which is in agreement with
the structure of our homology model based on Ca21-free
gelsolin (PDB id: 1D0N) but differs signiﬁcantly from the
homologymodel generated fromCa21-gelsolin bound to actin
(PDB id: 1RGI). We also examined changes in EgAFFP
conformation caused by Ca21 and found no signiﬁcant vari-
ations in the molecular envelope of the protein upon addition
of Ca21. The functional implications of the proposed struc-
tural model upon actin binding are discussed.
MATERIALS AND METHODS
Protein expression and puriﬁcation
Full-length EgAFFP (370 aa) (30) was expressed as a fusion with
glutathione-S-transferase using the pGEX system (Amersham Biosciences,
Uppsala, Sweden) and puriﬁed by afﬁnity chromatography according to
Smith and Johnson (39). The fusion protein was cleaved with thrombin
(10 units/mg of matrix-bound protein) for 12 h at 4C, and the recombinant
EgAFFP was eluted in phosphate-buffered saline (137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) plus 3 mM dithiothreitol
(DTT) and 1 mM phenylmethylsulfonyl ﬂuoride (PMSF) and concentrated
in Centricon YM-10 microconcentrators (Millipore, Bedford, MA) to 12
mg/ml. Protein purity was evaluated by SDS-PAGE (40), and concentration
was determined using the Bio-Rad dye assay (Bio-Rad, Hercules, CA),
with BSA as standard. Typically, 30 mg of recombinant protein were ob-
tained from 1 liter of culture.
Pyrene actin preparation
Pyrene actin was prepared according to Cooper et al. (41) with minor
modiﬁcations. Monomeric actin (G-actin) from bovine skeletal muscle
(Sigma-Aldrich, St. Louis, MO) was diluted in buffer G (2 mM Tris-HCl,
pH 8.0, 0.2 mM ATP, 0.5 mM DTT, 0.2 mM CaCl2, 0.01% NaN3) to a
concentration of 1 mg/ml. G-actin was polymerized at room temperature for
1 h by adding KCl and MgCl2 to 100 mM and 2 mM, respectively. N-(1-
pyrene) iodoacetamide (Molecular Probes, Eugene, OR) freshly dissolved in
dimethyl formamide was added from a 5 mM stock solution to the F-actin
(ﬁnal concentration of 160 mM) and incubated overnight at 4C in the dark.
The pyrene F-actin was collected by centrifugation at 163,000 3 g for 90
min at 4C, resuspended in 1 ml of buffer G, and dialyzed against the same
buffer for 48 h with several changes of buffer to depolymerize the actin and
remove free pyrenyl. The pyrene G-actin was then clariﬁed at 163,000 3 g
for 90 min at 4C and divided into 50 ml aliquots, which were frozen in
liquid nitrogen and stored at 70C. Before use, the pyrene G-actin was
thawed on ice and then centrifuged at 16,000 3 g for 15 min at 4C
to remove larger precipitates. After the absorbance at 344 nm and 290 nm
was determined, the total actin concentration was calculated using mM
actin ¼ (A290 – 0.127 A344)/26.6 mM1 cm1. The pyrene/actin ratio was
calculated using an extinction coefﬁcient of 22,000 M1 cm1 for pyrene
with pyrene/actin ¼ (A344/22.0)/mM actin.
Fluorescence spectroscopy
All ﬂuorescence measurements with pyrene actin were performed at 20C
using an ISS K2 ﬂuorimeter (ISS, Fluorescence, Analytical and Biomedical
Instrumentation; Champaign, IL). The excitation and emission wavelength
were set at 365 nm and 407 nm, respectively, with sample volumes of 300 ml.
To avoid bleaching the ﬂuorophore, pyrene actin was prepared and stored in
the dark and, during ﬂuorescence experiments, it was exposed to the light
source only intermittently. The data were plotted as arbitrary relative ﬂuo-
rescence values.
For nucleation assays, actin (6 mMﬁnal concentration, 10% of which was
pyrene labeled) was preincubated for 10 min with EgAFFP (250 nM). The
polymerization was initiated by the addition of buffer F (buffer G with 100
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mM KCl and 2 mM MgCl2) from a 103 concentrated stock solution, and
the increase in ﬂuorescence was recorded as a function of time.
For severing assays, actin (8 mM, 25% pyrene labeled) was polymerized
in buffer F for 15 min. Subsequently, the ﬁlaments were precapped with
recombinant gelsolin (23) (40 nM ﬁnal concentration) to avoid measuring
nucleation activity. The mixture was stored overnight on ice. This solution
was then diluted in buffer G to a ﬁnal concentration of 400 nM in the absence
or presence of EgAFFP (10 nM), and ﬂuorescence was recorded.
Modeling of EgAFFP
The PDB database was searched for proteins homologous to EgAFFP with
solved atomic structures using the BLAST program (42). The selected se-
quenceswere alignedwithCLUSTALW(43), andmodel building byhomology
was performed with the MODELLER 6 program (44). For a given alignment,
20 model structures were built and evaluated with the PROCHECK software
suite (45). Only the best-evaluated model was retained after the analysis.
SAXS measurements and data analysis
SAXS data were collected at the small-angle scattering beamline on the
LNLS (National Synchrotron Light Laboratory, Campinas, Brazil) using a
one-dimensional position-sensitive detector. EgAFFP samples at a concen-
tration of 4, 8, and 12 mg/ml were prepared in phosphate-buffered saline (pH
7.4) in the absence or presence of 0.2 mM CaCl2. EGTA was added to the
Ca21-free samples to a ﬁnal concentration of 1 mM. Samples were measured
at a wavelength of 1.488 A˚ for a sample-detector distance of 1634.5 mm
covering the momentum transfer range 0.21 nm1 , q , 2.35 nm1 (q ¼
4psinu/l, where 2u is the scattering angle). The scattering curves of the
protein solutions and the corresponding solvents were collected in 20 frames
of 100 s each to monitor radiation damage and beam stability. The data were
normalized to the intensity of the incident beam and corrected for detector
response. The scattering of the buffer was subtracted, and the difference
curves were scaled for concentration. The distance distribution functions
p(r) and the radii of gyration Rg were evaluated by indirect Fourier transform
using GNOM (46), which also corrected the smearing effect.
Ab initio molecular shape determination from
SAXS measurements
The low resolution particle shape was restored using the ab initio procedure
described by Petoukhov et al. (47), as implemented in the CREDO program.
The known part of the high resolution structure was ﬁxed, and missing
portions, such as disordered loops and N-terminal residues, were then
modeled to ﬁt the experimental scattering data obtained from the intact
particle. A simulated annealing procedure was used to minimize a scoring
function that depends on the discrepancy between the experimental and cal-
culated patterns and relevant penalty terms. The ﬁnal shape restoration was
performed using 436 residues and 378 waters assuming no molecular sym-
metry. The values for Rg, Dmax, and the scattering curve simulated from the
atomic coordinates of the EgAFFP homology models based both on Ca21-
free and Ca21-bound gelsolin and the discrepancies between the homology
model and experimental data were calculated using the CRYSOL program (48).
The SUPCOMB program (49) was used to superpose the low resolution ab
initio model to the structure of the homology model.
RESULTS
Functional integrity of recombinant EgAFFP
Recombinant EgAFFP functionality has been previously
assessed and, compared to gelsolin, EgAFFP nucleates actin
at a similar rate, whereas fragmentation is 20% less efﬁcient
(30). To assess recombinant EgAFFP functionality before its
structural characterization, the pyrene actin ﬂuorescence
assay was used to indirectly determine its actin-severing
and -nucleating activities by monitoring the polymerization/
depolymerization rate of actin. The ability of recombinant
EgAFFP to nucleate actin assembly (Fig. 1 A) and sever actin
ﬁlaments (Fig. 1 B) was conﬁrmed by its direct effect on the
rate of increase and decrease, respectively, in the ﬂuores-
cence of pyrene-labeled actin. These results indicated that
the recombinant EgAFFP samples used for structural char-
acterization retained these Ca21-dependent activities, which
are typical of proteins of the gelsolin superfamily.
EgAFFP modeling
Sequence alignments with the database of structures revealed
that the EgAFFP sequence has the highest sequence identity,
36% of identical residues and 58% of conserved residues,
with the N-terminal half (amino acids 27–367) of horse
plasma gelsolin (in the Ca21-free form, PDB id: 1D0N;
(25)). Relatively high homology and the fact that 1D0N is
the only full-length structure of the gelsolin superfamily avail-
able justiﬁed its use as a template for EgAFFP modeling. For
modeling, we aligned the EgAFFP target sequence to that of
amino acids 27–367 of the 1D0N template. The ﬁrst 35
FIGURE 1 (A) Nucleating and (B) severing activity of recombinant
EgAFFP. Assays were performed in the presence of Ca21 as described in
Materials and Methods. Nucleating activity of 60 nM EgAFFP (h).
Severing activity of 4 nM (n) and 10 nM ()) EgAFFP. Actin alone (s) was
used as a control in both assays.
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amino acids of the EgAFFP sequence, which would consist
of two short a-helices, were eliminated, since they did not
align with the template sequence. The obtained alignment
was then used to generate a homology model (Fig. 2,
shaded). As expected from the building procedure, the model
resembles the N-terminal half of the 1D0N structure
(domains G1–G3) and suggests that EgAFFP is composed
of three independent domains (E1, Phe49–Tyr143; E2,
Leu147–His255; and E3, Ser278–Trp368), as predicted by se-
quence analysis (30). Each domain adopts a similar geo-
metric fold composed of a core of mixed b-sheet comprising
ﬁve or six strands sandwiched between a long helix (helix 1)
running roughly parallel to the strands in the sheet, and a
short helix (helix 2) running approximately perpendicular to
the strands. The sheets of E1 and E3 form a continuous 10-
stranded b-sheet. E1 also contributes a single strand to the
sheet of E2, forming a continuous seven-stranded b-sheet.
The C-terminus of E1 immediately enters the N-terminus of
E2, whereas there is an extended 23-residue loop connecting
E2 and E3, which runs over the central sheet of E1. EgAFFP
was also modeled in the presence of Ca21, based on the
crystallographic structure of the Ca21-bound N-terminal half
(G1–G3 domains) of gelsolin:actin complex (PDB id: 1RGI;
(38)), from which the actin fragment was discarded. The
obtained model (Fig. 2, solid) shows that the two halves of
the b-sheet that runs continuously from E1 to E3 in the Ca21-
free model are separated in the Ca21-bound model, and E1 no
longer interacts with E3. In contrast, the E2–E3 linker
shortens and brings E2 close to E3, whereas the ﬁrst strand of
E2 extends, forming a long linker between E1 and E2.
SAXS data analysis
Experimental scattering curves from EgAFFP are presented
in Fig. 3, and the structural parameters derived from these
curves are given in Table 1. Guinier plots (50) of the data
obtained at 4 mg/ml exhibited linear proﬁles, indicating
satisfactory monodispersity of EgAFFP both in the absence
and in the presence of Ca21 (Fig. 3 A, inset). The scattering
curves obtained in the presence or in the absence of Ca21
were virtually identical at all measured protein concentra-
tions (Fig. 3 A). The radius of gyration (Rg), estimated using
the Guinier approximation, was 2.53 6 0.01 nm in the
absence of Ca21 and 2.51 6 0.01 nm in the presence of
Ca21. Since scattering curves at higher concentrations
showed nonnegligible interference effects, we combined a
low resolution part of the scattering curve obtained at 4 mg/
ml (,0.5 nm1) with a high resolution part of the scattering
curve measured at 12 mg/ml in a composed scattering curve,
which was used in ab initio model reconstruction (Fig. 3 B).
The pair distance distribution function p(r) for both protein
samples is shown in Fig. 4 and was calculated from the
GNOM ﬁtted data. These curves also provided the EgAFFP
maximum dimension (Dmax), determined from the value of r
for which the function p(r) drops to zero. The determined
EgAFFP Dmax was 8.0 6 1.0 nm, both in the absence and in
the presence of Ca21. The ratio of the radius of gyration to
the maximum dimension indicates an elongated shape for
EgAFPP in solution, also indicated by the shape of the p(r)
function, typical of an asymmetric particle (51). To evaluate
our computer-designed EgAFFP models, based on the struc-
ture of Ca21-free and Ca21-bound gelsolin domains G1–G3,
the SAXS experimental curves were compared to the scat-
tering intensity and the distance distribution p(r) function
calculated from their atomic coordinates. The scattering in-
tensity and the distance distribution p(r) curve calculated for
the EgAFFP Ca21-free homology model (presented in Figs.
3 B and 4, respectively) are in good agreement with the
SAXS experimental data, indicating that scattering data
are fully compatible with this structural model. Conversely,
both scattering intensity and distance distribution function
for the EgAFFP Ca21-bound model grossly deviate from the
scattering intensity curves and p(r) function obtained from
SAXS experiments (Figs. 3 B and 4).
Ab initio molecular shape determination from
SAXS experiments
The low resolution ab initio models of EgAFFP in the
absence and presence of calcium were both built using the
FIGURE 2 Stereo view of superposition of the EgAFFP homology model
based on Ca21-bound gelsolin (PDB id 1RGI) (solid) and EgAFFP homology
model based on Ca21-free gelsolin (PDB id 1D0N) (shaded). Domains E1,
E2, and E3 are indicated in each model. The relative positions of both models
were based on the superposition of the corresponding E1 domains.






Parameter/sample Exp.* Mod.y DRz Exp.* Mod.y DRz
Dmax (nm) 8.00 6 1.00 7.68 8.53 8.00 6 1.00 9.02 8.47
Rg (nm) 2.53 6 0.01 2.37 2.35 2.51 6 0.01 2.71 2.29
Discrepancy x – 1.29 1.15 – 6.00 1.13
Resolution (nm) 2.67 – 2.67 2.67 – 2.67
*Exp., calculated from the experimental data.
yMod., parameters obtained from the EgAFFP homology models.
zDR, parameters of the experimental SAXS low resolution structure,
averaged over 10 independent DR models.
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CREDO program from the composed x-ray scattering curves.
The models were derived from experimental data assuming
P1 symmetry. To verify the validity of the dummy residue
(DR) models, several independent constructions were made
from different starting conditions and, in all cases, very
similar envelopes were obtained. Virtually identical low
resolution models were also obtained when the GASBOR
program (52) was used. The homology model of EgAFFP
based on Ca21-free gelsolin, but not the model based on the
Ca21/gelsolin:actin complex, could be unambiguously po-
sitioned inside the SAXS-derived molecular envelopes
of EgAFFP both in the absence and in presence of Ca21
(Fig. 5). The structural parameters calculated for the DR
models and the Ca21-free EgAFFP homology model and the
structural parameters obtained from experimental SAXS
measurements (all presented in Table 1) show very good
agreement, further supporting our computer-designed Ca21-
free EgAFFP structure. Furthermore, molecular envelopes
obtained from the SAXS curves measured for EgAFFP in the
absence and presence of Ca21were virtually identical, as one
would expect given the extremely high similarity of the
initial scattering curves (Fig. 3). At the same time, structural
parameters derived from the EgAFFP homology model
based on the Ca21-bound gelsolin:actin complex are very
different from the experimental data (Table 1). Moreover,
ﬁtting of the predicted x-ray scattering curve based on this
model with the experimental scattering data (with and without
Ca21) indicates gross differences between these curves (Fig.
3 B), which results in a discrepancy parameter x ¼ 6.0.
Given the fact that the structure of the N-terminal half of
gelsolin (domains G1–G3) closely resembles its C-terminal
half (domains G4–G6), we also compared the predicted x-ray
scattering intensity curves and distance distribution for
crystallographic models of G4–G6 domains of Ca21-bound
gelsolin (PDB id: 1NPH (53)) and Ca21/actin:gelsolin
FIGURE 3 Experimental scattering curves for EgAFFP. (A) Experimental
scattering curves corrected by the smearing effect of EgAFFP in the absence
of Ca21 at 4 mg/ml (h), 8 mg/ml (s), and 12 mg/ml (n) and in the presence
of Ca21 at 4 mg/ml (=), 8 mg/ml ()), and 12 mg/ml (9). The Guinier plot
with linear ﬁt proﬁles is shown in the inset, allowing the estimation of
Rg ¼ 2.53 nm in the absence of Ca21, and Rg ¼ 2.51 nm in the presence of
Ca21. (B) Composed scattering curve of EgAFFP corrected by the smearing
effect in the absence of Ca21 (h), in the presence of Ca21 (s), and scat-
tering intensities from the DR models (thick solid line), from the homology
model based on the N-terminal half of Ca21-free gelsolin (PDB id 1D0N,
thick shaded line), from the homology model based on the N-terminal half of
Ca21-bound gelsolin (PDB id 1RGI, traced line), from the crystallographic
structure of the Ca21-bound C-terminal half of gelsolin (PDB id 1NPH, thin
shaded line), and from the x-ray structure of the C-terminal half of gelsolin
bound to Ca21 and actin (PDB id 1H1V, thin solid line). The actin structure
was extracted from the later model.
FIGURE 4 Comparison of distance distribution functions for EgAFFP.
The p(r) curves obtained were calculated using the GNOM program, and the
experimentally derived distributions for EgAFFP are given in the absence
(h) and in the presence (s) of Ca21. Distributions were calculated for the
homology model based on the N-terminal half of Ca21-free gelsolin (PDB id
1D0N, thick shaded line), for the homology model based on the N-terminal
half of Ca21-bound gelsolin (PDB id 1RGI, traced line), for the
crystallographic structure of the Ca21-bound C-terminal half of gelsolin
(PDB id 1NPH, thin shaded line), and for the x-ray structure of the
C-terminal half of gelsolin bound to Ca21 and actin (PDB id 1H1V, thin
solid line). The actin structure was extracted from the later model.
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complex (PDB id: 1H1V (54)). Actin structure was removed
from the later model. Both G4–G6 gelsolin structures agree
with the experimental x-ray scattering curves signiﬁcantly
better than the EgAFFP model based on Ca21-bound G1–G3
domains of gelsolin (Fig. 3 B; x ¼ 1.77 for 1NPH and x ¼
1.78 for 1H1V crystallographic models, respectively) but not
as well as the EgAFFP model based on the Ca21-free G1–G3
gelsolin structure. Distance distribution functions for G4–G6
gelsolin domains also show smaller deviations from the ex-
perimentally derived curve as compared to the EgAFFP
model based on Ca21-bound G1–G3 gelsolin domains but
not when compared with the model based on the Ca21-free
G1–G3 gelsolin structure (Fig. 4).
DISCUSSION
We have previously cloned and expressed a functional three
domain EgAFFP and demonstrated that this protein has two
actin-binding sites and is regulated by calcium (30). To un-
derstand how this protein functions and is regulated by
calcium, we started its structural characterization. Our attempts
to solve its structure by x-ray crystallography have not been
successful so far due to problems with protein crystallization.
Therefore, we have used the alternative approaches of SAXS
studies and molecular homology modeling to obtain struc-
tural information on EgAFFP.
Overall SAXS results (Rg, Dmax, and DR models) indicate
that EgAFFP in solution both in the presence and in the
absence of Ca21 is an asymmetric elongated protein. This is
in agreement with the homology model based on the Ca21-
free gelsolin structure (PDB id 1D0N) in which domains E1
and E3 are gathered at one side of the protein, forming an
intimate contact through a continuous b-sheet, whereas E2 is
relatively apart from them, on the other side. Small differ-
ences in Rg and Dmax between the SAXS measurements and
the homology model are probably due to subtle variations in
position and orientation of the three distinct domains and
their connecting loops in the model.
Comparison of x-ray data obtained in the absence and in
the presence of Ca21 indicates that Ca21 does not signiﬁ-
cantly change x-ray scattering curves, rendering practically
identical radii of gyration, maximum dimensions, and overall
shapes of the protein in both Ca21-free and Ca21-bound
states. This is surprising, since the homologous six domain
protein, gelsolin, is known to suffer drastic domain shifts
upon interaction with Ca21 alone (53–56) or with Ca21 and
actin (38). As a consequence, EgAFFP homology models
based on these two different structural templates (Ca21-free
gelsolin and Ca21/gelsolin:actin complex, domains G1–G3)
have very different molecular shapes (Fig. 2). However, only
one of them (the Ca21-free gelsolin-based model) is in
agreement with the experimental SAXS data measured from
the EgAFFP samples both in the absence and in the presence
of Ca21, suggesting that addition of Ca21 alone is not suf-
ﬁcient to promote conformational changes in EgAFFP similar
to those observed in the Ca21-boundN-terminal half of gelsolin:
actin complex.
EgAFFP is more similar to the N-terminal half (36% of
identical residues and 58% of conserved residues) than to the
C-terminal half of gelsolin (29% of identical residues and
43% of conserved residues). Therefore, the G1–G3 gelsolin
structure (in its Ca21-free form) was used for homology
modeling. The predicted x-ray data for G4–G6 gelsolin
structures also agree with the experimental x-ray scattering
curves but less consistently than the model based on the
G1–G3 Ca21-free gelsolin structure.
FIGURE 5 Stereo views showing the superposition of the Ca21-free
EgAFFP homology model with the envelope obtained from the 10 DR
models (spheres). Only DR models retrieved from the Ca21-free EgAFFP
scattering curves are shown since these are virtually identical to the DR
models based on Ca21-bound EgAFFP scattering curves. Middle and
bottom images are rotated by 90 around the y and x axes, respectively,
compared to the top image.
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In EgAFFP, at least one actin-binding site is known to be
Ca21 dependent (30), but apparently the mere binding of
Ca21 does not determine structural changes large enough to
be detected by SAXS. It is possible that more signiﬁcant
domain shifts would depend upon actin binding to EgAFFP,
characterizing a different behavior from that of gelsolin, in
which calcium activation triggers large domain movements
both in the N- and C-terminal halves (53–59). This issue re-
mains to be experimentally addressed for EgAFFP.
In gelsolin, Ca21 activation is mediated by type 1 and type
2 Ca21-binding sites (54). Type 1 Ca21-binding sites are
shared between actin and gelsolin domains, allowing the
prediction that those domains will bind G-actin in a Ca21-
sensitive matter. Type 2 Ca21-binding sites are completely
contained within gelsolin domains, facilitating disruption of
interactions between domains to release latches and render
the activated gelsolin able to bind actin (59). Results ob-
tained through sequence alignment and the molecular
homology model (data not shown) indicate that EgAFFP
has one type 1 Ca21-binding site, located on the ﬁrst domain
(E1), and three type 2 Ca21-binding sites, one on each do-
main. Considering this is the same organization found in each
half of gelsolin, the different EgAFFP behavior upon Ca21
binding cannot be simply attributed to the nature of Ca21-
binding sites.
It has been shown that an acidic pH could induce con-
formational changes in gelsolin similar to those predicted to
occur upon Ca21 binding (60). Therefore, we cannot discard,
at least formally, the hypothesis that the conformational
differences between Ca21-bound EgAFFP and Ca21-bound
gelsolin are due, at least to some extent, to differences in pH
conditions in which EgAFFP SAXS measurements (this
work) and gelsolin crystallization (38) were performed. It
would be possible that gelsolin crystallization at an acidic pH
(4.7) could have induced the large conformational change
observed in its N-terminal (G1–G3) domains.
In conclusion, based on the low resolution ab initio struc-
tures and the Ca21-free homology model, we can infer that
EgAFFP is a compact protein very similar to the N-terminal
half of Ca21-free gelsolin. In contrast to what has been de-
scribed for six domain members of the gelsolin family, the
addition of Ca21 does not result in major conformational
changes in EgAFFP, suggesting a distinct functioning mech-
anism for three domain members of the gelsolin family.
Subtle structural changes of regulatory relevance upon Ca21
binding are likely to occur, but their study will possibly
require EgAFFP crystallization. It also remains to be clariﬁed
how actin-binding would affect EgAFFP conformation and
how EgAFFP binds to and severs F-actin.
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